Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...

College of Pharmacy, Vessel-Organ Interaction Research Center (VOICE, MRC), Kyungpook National University, Daegu, Republic of Korea.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: Marc Ladanyi, Department of Pathology and Laboratory Medicine, Memorial ...

Department of Oncology, VIB-KU Leuven Center for Cancer Biology, and KU Leuven, Leuven, Belgium.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

Nearly a year after alarms about CAR T-cell therapies possibly causing secondary lymphomas, studies suggest that genetic predisposition—not vector integration—are likely the primary cause of these ...

Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts. Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Gastrointestinal Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Center of Excellence for Leukemia Studies, St. Jude Children’s Research Hospital, Memphis, Tennessee.